用黄类药物治疗盆腔拥堵综合征的医学治疗:试点研究
I-Hui Lee1, Tzu-Yin Lin1, Shen Sun2
1Department of Obstetrics and Gynecology, Taipei City Hospital, Ren-Ai Branch, Taipei, Taiwan.
Taiwanese journal of obstetrics & gynecology
|March 6, 2025
概括
黄类药物治疗显著减少了卵巢静脉直径,并改善了患有盆腔拥堵综合征 (PCS) 的女性的生活质量. 这表明黄类药物可能是PCS的第一线治疗选择.
科学领域:
- 血管医学 血管医学
- 妇科 妇科 妇科 妇科
- 药理学 药理学是指药理学的学科.
背景情况:
- 盆腔拥堵综合征 (PCS) 是一种疾病,其特点是由于静脉拥堵而引起的慢性盆腔疼痛.
- 目前对PCS的管理选择可能是侵入性的或有效性有限的.
研究的目的:
- 为了评估使用黄类药物在被诊断患有盆腔拥堵综合征的妇女的医疗管理的有效性.
- 评估黄类药物治疗对卵巢静脉直径和患者生活质量的影响.
主要方法:
- 11名被诊断患有PCS的妇女接受了3-6个月的黄类药物治疗 (每天两次500毫克或每天一次1000毫克).
- 卵巢静脉直径测量使用治疗前和治疗后的经阴道超声波.
- 盆腔静脉静脉问卷 (PVVQ) 和视觉模拟量表 (VAS) 用于评估症状严重程度和生活质量.
主要成果:
- 黄类药物治疗导致平均卵巢静脉直径从8.1毫米显著减少到6.2毫米 (p=0.016).
- 患者报告PCS症状显著改善,平均VAS得分从5.9降至2.5 (p=0.005),平均PVVQ得分从51.6降至30.5 (p=0.005).
结论:
- 用黄类药物的医疗治疗有效地减少了患有盆腔拥堵综合征的患者的卵巢静脉直径.
- 黄类药物治疗显著改善了患有PCS的女性的生活质量.
- 黄类药物显示出作为第一线治疗盆腔拥堵综合征的有前途的医学治疗方法.
相关概念视频
02:59Cancer Prevention
6.0K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.0K
01:21Drugs for Treatment of Constipation-Predominant IBS
124
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
124